News and events
We publish news, events, departmental media releases and health alerts so you are informed about the latest health updates
Public forums will be held in July and August 2018 to consult on the future priorities of the Medical Research Future Fund (MRFF).
The Australian Technical Advisory Group on Immunisation (ATAGI) has new advice to support school based immunisation providers with the introduction of Gardasil®9 in a 2-dose schedule from January 2018.
A $100 million research fund set up by the Government aims to double survival rates for brain cancer over the next ten years, with the ultimate goal of one day defeating brain cancer.
The 2018–19 Budget includes a $1.3 billion Health and Medical Industry Growth plan to drive a new era of better health care while fuelling jobs and growth in new firms and industries through research.
A revolutionary 3D BioPen that uses stem cells to create cartilage is one of the innovative research projects being funded by the Australian Government.
Annual vaccination is the most effective way of reducing the impact of the flu in the community, especially in residential aged care facilities.
Recent data released by the Australian Immunisation Register shows coverage rates amongst Australian children continue to improve.
Advice on the presence of natural rubber latex in the sheath covering the needle of the Fluad trivalent influenza vaccine. Anyone who has a severe allergy to latex should not receive Fluad.
Annual influenza vaccination is recommended for all persons aged six months and over (unless contraindicated) to reduce their chance of becoming ill with influenza.
The Australian Technical Advisory Group on Immunisation is consulting with stakeholders on proposed changes to meningococcal and Haemophilus influenzae type B vaccination recommendations for inclusion in the Australian Immunisation Handbook.